Kerr Drug Financial Analyst Salaries in Wilmington, DE | Comparably
Kerr Drug is a pharmacy that sells prescription and over the counter drugs. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
140

Kerr Drug Financial Analyst Salaries in Wilmington, DE

The average Kerr Drug Financial Analyst in Wilmington, DE earns an estimated $69,857 annually, which includes an estimated base salary of $65,257 with a $4,600 bonus. Kerr Drug's Financial Analyst compensation is $17,553 less than the US average for a Financial Analyst. Financial Analyst salaries at Kerr Drug in Wilmington, DE can range from $66,000 - $75,000.

In Wilmington, DE, The Finance Department at Kerr Drug earns $16,640 more on average than the Admin Department.

Last updated 5 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$69,857
Average Compensation
$65,257
avg. base
$4,600
avg. bonus

Financial Analyst Salaries at Kerr Drug

In Wilmington, DE, Financial Analysts earn $1,550 more than Financial Analysts, and $773 less than Accountants.

Accounting Manager
$121k*
Business Analyst
$95k*
Senior Accountant
$92k*
Accountant
$71k*
Financial Analyst
$68k*
* estimated salary

Compensation at Kerr Drug by Department

In Wilmington, DE, The Finance Department averages $16,640 more than the Admin Department, and $10,794 less than the IT Department

IT
$95,496 Avg. total comp.
+$11k
Finance
$84,702 Avg. total comp.
Admin
$68,062 Avg. total comp.
-$17k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Kerr Drug reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Kerr Drug reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at Kerr Drug Rate Their Compensation

The majority of Financial Analysts at Kerr Drug believe they're compensated fairly. 100% of Financial Analysts at Kerr Drug say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Kerr Drug

×
Rate your company